This is further to the intimation given by the Company dated August 23 2024 the US-FDA had Conducted an inspection at Companys manufacturing facility located at Baddi Himachal Pradesh in the month of August 2024.
FDC: Receipt Of Establishment Inspection Report (EIR) From US FDA With No Observations (Zero 483 S) As Closure Of Inspection Conducted At Company''s Manufacturing Facility Located At Baddi Himachal Pradesh.
November 13, 2024
Download PDF
FDC
Informed fund ideas, better judgment. Every month. Mutual Fund Insight, every month since October 2002.
Take charge. Know more. Keep more. Mutual Fund Insight helps you do all three — every month